| Literature DB >> 31562382 |
Qing Zhang1, Ye Zhang1, Chen Xin1, Yingyan Mao1, Kai Cao1, Catherine Jan1,2, Chunyu Guo3, Ningli Wang4, Ravi Thomas1,5,6.
Abstract
BACKGROUND/Entities:
Mesh:
Year: 2019 PMID: 31562382 PMCID: PMC7182556 DOI: 10.1038/s41433-019-0600-2
Source DB: PubMed Journal: Eye (Lond) ISSN: 0950-222X Impact factor: 3.775
Fig. 1Subject selection and reasons for exclusion
Characteristics of included and excluded participants
| Inclued ( | Excluded ( | ||
|---|---|---|---|
| Age (years) | 51.12 ± 10.80 | 54.31 ± 13.83 | <0.001 |
| SBP (mmHg) | 139.11 ± 21.74 | 137.82 ± 23.65 | 0.026 |
| DBP (mmHg) | 78.14 ± 12.16 | 76.07 ± 11.99 | <0.001 |
| BMI | 24.64 ± 3.65 | 24.24 ± 3.96 | 0.002 |
| W/H ratio | 0.90 ± 0.06 | 0.90 ± 0.10 | 0.969 |
| CSFP (mmHg) | 12.26 ± 3.29 | 11.38 ± 3.64 | <0.001 |
| IOP (mmHg) | 15.11 ± 2.80 | 14.84 ± 3.29 | 0.001 |
| TLCPD (mmHg) | 2.86 ± 3.67 | 3.23 ± 4.32 | 0.001 |
| AL (mm) | 22.79 ± 0.76 | 22.86 ± 1.2 | 0.056 |
| DA (mm2) | 2.24 ± 0.43 | 2.26 ± 0.40 | 0.379 |
| CRAE (μm) | 157.39 ± 22.06 | 150.38 ± 31.62 | <0.001 |
| CRVE (μm) | 240.87 ± 33.02 | 228.44 ± 38.74 | <0.001 |
| AVR | 0.66 ± 0.07 | 0.66 ± 0.13 | 0.002 |
| Maximum cup depth (mm) | 0.58 ± 0.22 | 0.58 ± 0.21 | 0.936 |
| Gender (male%) | 1882 (44.4%) | 1281 (49.3%) | <0.001 |
| Diabetes (%) | 237 (6.2%) | 150 (8.5%) | 0.001 |
| Hypertension (%) | 2057 (48.6%) | 1140 (46.1%) | 0.05 |
| POAG (%) | 40 (0.9%) | 27 (1.1%) | 0.61 |
Continuous data are represented as mean ± SD; and categorical data are represented as n (%) for overall. Comparisons between groups were performed with independent-samples t-test for continuous data, and Pearson’s Chi-square test or Fisher’s exact test for categorical data
SBP systolic blood pressure, DBP diastolic blood pressure, IOP intraocular pressure, AL axial length, DA disc area, CRAE central retinal arteriolar equivalent, CRVE central retinal venular equivalent, AVR CRAE/CRVE ratio, W/H ratio Waist-to-hip ratio, BMI body-mass-index, POAG primary open-angle glaucoma, CSFP estimated cerebro-spinal fluid pressure, TLCPD lower estimated trans-laminal cribrosa pressure difference
P < 0.05, indicated a significant difference found between the included group and the excluded group
Univariable analysis of the associations between the maximum cup depth (mm) and ocular and systemic parameters of the Handan eye study (40 POAG and 4194 non-glaucoma)
| Parameters | Coefficient | 95% CI of | |
|---|---|---|---|
| Age (years) | <0.001 | −0.003 | −0.004, −0.003 |
| AL (mm) | <0.001 | 0.025 | 0.017, 0.033 |
| IOP (mmHg) | 0.006 | 0.003 | 0.001, 0.006 |
| TLCPD (mmHg) | 0.006 | −0.003 | −0.004, −0.001 |
| CSFP (mmHg) | <0.001 | 0.006 | 0.004, 0.008 |
| DA (mm2) | <0.001 | 0.210 | 0.210, 0.236 |
| CRAE (μm) | <0.001 | −0.001 | −0.001, 0.000 |
| CRVE (μm) | 0.003 | −0.0003 | 0.000, 0.000 |
| SBP (mmHg) |
| ||
| DBP (mmHg) | 0.800 | <0.001 | 0.000, 0.001 |
| AVR | 0.340 | −0.046 | −0.143, −0.050 |
| W/H ratio | 0.170 | 0.080 | −0.036, 0.199 |
| BMI (kg/m2) | 0.150 | −0.001 | −0.003, 0.000 |
| Female | <0.001 | −0.044 | −0.057, −0.031 |
| Male | |||
| No | |||
| Yes | 0.072 | −0.026 | −0.053, 0.002 |
| No | |||
| Yes | <0.001 | −0.032 | −0.045, 0.018 |
P-value = statistical significance of the association
CI = confidence interval
Coefficient β = Regression Coefficient (un-standardized Beta)
SBP systolic blood pressure, DBP diastolic blood pressure, IOP intraocular pressure, AL axial length, DA disc area, CRAE central retinal arteriolar equivalent, CRVE central retinal venular equivalent, AVR CRAE/CRVE ratio, W/H ratio Waist-to-hip ratio, BMI body-mass-index
aNote: Gender, diabetes, hypertension was analyzed by mixed linear model
Multivariable analysis of the determinants of the Maximum Cup Depth of the Handan Eye Study (40 POAG and 4194 non-glaucoma)
| Parameter | Regression | Standardized | 95% Confidence | Variance inflation | |
|---|---|---|---|---|---|
| DA (mm2) | <0.001 | 0.20 | 0.42 | 0.19, 0.22 | 1.05 |
| Gender | <0.001 | −0.04 | −0.08 | −0.05, −0.02 | 1.03 |
| Age (years) | <0.001 | −0.002 | −0.09 | −0.003, −0.001 | 1.07 |
| Presence of POAG | <0.001 | 0.17 | 0.08 | 0.11, 0.23 | 1.02 |
| CRAE (μm) | <0.001 | −0.001 | −0.06 | −0.001, −0.0003 | 1.01 |
| IOP (mmHg) | 0.009 | 0.003 | 0.04 | 0.001, 0.005 | 1.03 |
| DA (mm2) | <0.001 | 0.20 | 0.41 | 0.19, 0.22 | 1.05 |
| Age (years) | <0.001 | −0.002 | −0.10 | −0.003, −0.001 | 1.07 |
| Gender | <0.001 | −0.04 | −0.09 | −0.05, −0.03 | 1.03 |
| Presence of POAG | <0.001 | 0.17 | 0.07 | 0.10, 0.24 | 1.02 |
| CRAE (μm) | <0.001 | −0.001 | −0.06 | −0.001, −0.0003 | 1.01 |
| IOP (mmHg) | 0.005 | 0.003 | 0.04 | 0.001, 0.005 | 1.03 |
Model 1: adjusted for the DA, AGE, GENDER, SBP, AL, IOP, CRAE, CRVE, HYPERTENSION, DM, POAG. The Durbin–Watson value: 1.98
Model 2: adjusted for the same variables in model 1 plus estimated CSFP and TLCPD. The Durbin–Watson value: 1.99
DA disc area, CRAE central retinal arteriolar equivalent, IOP intraocular pressure
Fig. 2The boxplot of distribution of CRAE by different percentiles. P stands for percentiles